New registry aims to unlock secrets of rare childhood blood cancers

NCT ID NCT07410247

Recruiting now Knowledge-focused Sponsor: University of Erlangen-Nürnberg Medical School Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study creates a nationwide registry and biobank for children diagnosed with myeloproliferative neoplasms (MPNs)—rare blood cancers that cause overproduction of blood cells. By collecting medical data and blood samples from up to 500 children across Germany, researchers hope to understand how these diseases differ in children versus adults. The goal is to improve diagnosis, identify those at risk for complications, and develop better treatments tailored to young patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this registry could provide crucial insights into how MPNs affect children, leading to better diagnosis and tailored treatments for this rare group.
What could go wrong: This is an observational registry, not a treatment trial. It collects data but does not test any therapy, so direct patient benefits may take years to emerge.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHILDHOOD MYELOPROLIFERATIVE NEOPLASMS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acquired polycythemia vera cellular phase chronic idiopathic myelofibrosis essential thrombocythemia myeloproliferative neoplasm primary myelofibrosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHILDHOOD MYELOPROLIFERATIVE NEOPLASMS

Contacts and locations

Locations

Department of Pediatrics and Adolescent Medicine, University Hospital Erlangen, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany
RECRUITING

Erlangen, Bavaria, D-91054, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.